Related Experiment Video

Updated: Jul 18, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

Suzanne Carreira1, Jane Goodall, Laurence Denat

  • 1Signalling and Development Laboratory, Marie Curie Research Institute, Oxted, Surrey, RH8 0TL, United Kingdom.

Genes & Development
|December 22, 2006
PubMed

Insights

Melanoma invasiveness is epigenetically controlled by the microphthalmia-associated transcription factor (Mitf). Mitf regulates the DIAPH1 gene, impacting cell invasiveness and proliferation through dynamic epigenetic mechanisms.

Area of Science:

  • Cancer Biology
  • Epigenetics
  • Melanoma Research

Background:

  • Metastatic melanoma is often attributed to genetic mutations and clonal evolution.
  • The role of epigenetic regulation in melanoma cell invasiveness remains an area of active investigation.

Purpose of the Study:

  • To investigate the epigenetic regulation of melanoma cell invasiveness.
  • To elucidate the role of the microphthalmia-associated transcription factor (Mitf) in melanoma progression.

Main Methods:

  • Analysis of Mitf regulation of the DIAPH1 gene in melanoma cells.
  • Assessment of actin cytoskeleton dynamics and cell invasiveness.
  • Investigation of cell cycle regulation, including p27(Kip1) degradation.

Main Results:

  • Mitf epigenetically regulates the DIAPH1 gene, which encodes the diaphanous-related formin Dia1.
  • Low Mitf levels decrease Dia1 expression, leading to actin cytoskeleton reorganization and increased ROCK-dependent invasiveness.
  • Mitf also controls p27(Kip1) degradation, influencing cell cycle arrest and proliferation.

Conclusions:

  • Mitf acts as a key epigenetic regulator of melanoma cell invasiveness and proliferation.
  • Mitf-mediated regulation of Dia1 impacts both cell migration and cell cycle progression.
  • Environmental cues modulating Mitf activity dynamically control melanoma cell differentiation, proliferation, and invasiveness.

More Related Videos

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model10:23

Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

Published on: November 13, 2012

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...